Enso Partners with My Life Centre to Open 2 More ECP Centres

Enso S&A Health House Sdn. Bhd. (Enso) has just enter into a partnership with My Life Centre (MLC) to open 2 more new ECP Centres in Johor Bahru & Kota Bahru for alternative medicine and therapy. Approximately 3 months ago, Enso took over "The Living Centre & The Living Clinic" which is located at Sunway Geo, Petaling Jaya. With the addition of the 2 new centres, it is forecasted that Enso revenue will increase to RM24million in 2020 from a revenue of RM12million in 2019 giving it 100% growth. With the growth of a large middle class, Enso provides non-invasive MDA and FDA medical devices and services endorsed by the authorities and managed by qualified medical team.

ECP (External Counter Pulsation) is a clinically tested as a non-invasive medical device where no drug and no external pain is administered during the treatment. As such, it's a safer therapy for all walks of life under certain medical conditions. Over the course of last few decades, it has evolved into the modern ECP therapy, which has proven to be a safe, effective, and low-cost, non-invasive treatment for patients with debilitating angina and chronic heart failures who are poor candidates for revascularization procedures and have suboptimal results from others. Patients with severe angina who are not considered to be candidates for angioplasty or bypass surgery may benefit from external counter pulsation, and ECP is an affordable treatment that many middle-income groups can afford. Dato' Seri Dr. Santhosh Satha, the Executive Chairman of Enso, remarked that, "With the growing educated and middle income class in Malaysia, people are more health conscious and aspire to live a healthier life because they can now afford it, thus prolonging the average Malaysian's life span; and Enso is in the middle of such wellness revolution, capitalising on the demand of this market."

Enso has also recently been nominated for the Global Business Leadership Awards 2020, and will receive the awards during the awards ceremony at the end of March 2020. The award is a testament that Enso is building on the continuous success of the company based on the Sustainable Development Goals (SDG) of the United Nations. The award will represent the most prestigious form of recognition for the company globally on leadership in business success, leadership in sustainability and the potential of achieving triple bottom line success. Enso is selected based on the criteria that are aligned to the 17 Goals of the SDG.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the reproduced articles,

please email: Julia.Zhang@ubmsinoexpo.com to motify or remove the content.